##gff-version 3
##sequence-region Q6UWZ7 1 409
Q6UWZ7	UniProtKB	Chain	1	409	.	.	.	ID=PRO_0000278575;Note=BRCA1-A complex subunit Abraxas 1	
Q6UWZ7	UniProtKB	Domain	7	160	.	.	.	Note=MPN;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU01182	
Q6UWZ7	UniProtKB	Coiled coil	206	260	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q6UWZ7	UniProtKB	Motif	406	409	.	.	.	Note=pSXXF motif;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q6UWZ7	UniProtKB	Modified residue	48	48	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q8BPZ8	
Q6UWZ7	UniProtKB	Modified residue	386	386	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:21406692;Dbxref=PMID:18669648,PMID:20068231,PMID:21406692	
Q6UWZ7	UniProtKB	Modified residue	387	387	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:21406692;Dbxref=PMID:18669648,PMID:20068231,PMID:21406692	
Q6UWZ7	UniProtKB	Modified residue	390	390	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:19690332,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:21406692,ECO:0000244|PubMed:23186163;Dbxref=PMID:18669648,PMID:19690332,PMID:20068231,PMID:21406692,PMID:23186163	
Q6UWZ7	UniProtKB	Modified residue	404	404	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26778126;Dbxref=PMID:26778126	
Q6UWZ7	UniProtKB	Modified residue	406	406	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:19690332,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:23186163,ECO:0000269|PubMed:17525340,ECO:0000269|PubMed:17643121,ECO:0000269|PubMed:17643122,ECO:0000269|PubMed:26778126;Dbxref=PMID:18669648,PMID:19690332,PMID:20068231,PMID:23186163,PMID:17525340,PMID:17643121,PMID:17643122,PMID:26778126	
Q6UWZ7	UniProtKB	Alternative sequence	1	109	.	.	.	ID=VSP_058196;Note=In isoform 2. Missing	
Q6UWZ7	UniProtKB	Natural variant	239	239	.	.	.	ID=VAR_030790;Note=A->T;Dbxref=dbSNP:rs752929794	
Q6UWZ7	UniProtKB	Natural variant	348	348	.	.	.	ID=VAR_054054;Note=Common polymorphism not associated with susceptibility to breast cancer. A->T;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:14702039,ECO:0000269|PubMed:18695986,ECO:0000269|PubMed:22357538;Dbxref=dbSNP:rs12642536,PMID:14702039,PMID:18695986,PMID:22357538	
Q6UWZ7	UniProtKB	Natural variant	361	361	.	.	.	ID=VAR_071865;Note=In BC%3B results in reduced DSB repair efficiency%3B primarily localizes to the cytoplasm and has reduced nuclear localization%3B does not affect interaction with BRCA1%3B results in highly reduced interaction with UIMC1/RAP80. R->Q;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:22357538,ECO:0000269|PubMed:25105795;Dbxref=dbSNP:rs201627097,PMID:22357538,PMID:25105795	
Q6UWZ7	UniProtKB	Natural variant	373	373	.	.	.	ID=VAR_054055;Note=Common polymorphism not associated with susceptibility to breast cancer. D->N;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12975309,ECO:0000269|PubMed:18695986,ECO:0000269|PubMed:22357538;Dbxref=dbSNP:rs13125836,PMID:12975309,PMID:18695986,PMID:22357538	
Q6UWZ7	UniProtKB	Mutagenesis	400	400	.	.	.	Note=No effect on formation of a heterotetramer with BRCA1. F->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26778126;Dbxref=PMID:26778126	
Q6UWZ7	UniProtKB	Mutagenesis	402	402	.	.	.	Note=Decreases formation of a heterotetramer with BRCA1. E->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26778126;Dbxref=PMID:26778126	
Q6UWZ7	UniProtKB	Mutagenesis	403	403	.	.	.	Note=No effect on formation of a heterotetramer with BRCA1. Y->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26778126;Dbxref=PMID:26778126	
Q6UWZ7	UniProtKB	Mutagenesis	404	404	.	.	.	Note=No effect on homodimerization. Mildly decreased recruitment of BRCA1 to sites of DNA damage. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26778126;Dbxref=PMID:26778126	
Q6UWZ7	UniProtKB	Mutagenesis	404	404	.	.	.	Note=Permits formation of a heterotetramer with BRCA1. S->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26778126;Dbxref=PMID:26778126	
Q6UWZ7	UniProtKB	Mutagenesis	404	404	.	.	.	Note=Abolishes formation of a heterotetramer with BRCA1. Does not affect interaction with a first BRCA1 chain. S->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26778126;Dbxref=PMID:26778126	
Q6UWZ7	UniProtKB	Mutagenesis	406	406	.	.	.	Note=Abolishes phosphorylation of the pSXXF motif and the interaction with BRCA1 but does not affect the interaction with UIMC1/RAP80. Strongly decreases recruitment of BRCA1 to sites of DNA damage. No effect on homodimerization. S->A;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17525340,ECO:0000269|PubMed:17643121,ECO:0000269|PubMed:17643122,ECO:0000269|PubMed:26778126;Dbxref=PMID:17525340,PMID:17643121,PMID:17643122,PMID:26778126	
